Drug
Brenipatide
Brenipatide: highest development phase Phase 2, developed by Eli Lilly. 4 trial records tracked on RxWires.
- Highest phase
- Phase 2
- Developer
- Eli Lilly
Trials
| Drug | Phase | Indication |
|---|---|---|
| Brenipatide NCT07219173 | Phase 2 | Asthma |
| Brenipatide NCT07928245 | Phase 2 | Major Depressive Disorder |
| Brenipatide NCT07286175 | Phase 2 | Bipolar Disorder |
| Brenipatide NCT07759245 | Phase 2 | Pulmonary Disease, Chronic Obstructive |
Latest
No recent events.
Follow Brenipatide on RxWires to get trial status changes, FDA actions, filings and patent dates as they happen.
Sourced from ClinicalTrials.gov, openFDA, SEC EDGAR and the FDA Orange Book. Not investment or medical advice.